Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.41 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL486944 | 1.00 | FAAH (0.47) | FAAHZDHHC7TDP1MEN1KMT2A | |
| SCHEMBL6309982 | 1.00 | FAAH (0.47) | FAAHZDHHC7TDP1MEN1KMT2A | |
| SCHEMBL1393537 | 1.00 | FAAH (0.47) | FAAHZDHHC7TDP1MEN1KMT2A | |
| SCHEMBL11358682 | 1.00 | FAAH (0.47) | FAAHZDHHC7TDP1MEN1KMT2A | |
| SCHEMBL1393272 | 1.00 | FAAH (0.47) | FAAHZDHHC7TDP1MEN1KMT2A | |
| SCHEMBL4904972 | 1.00 | FAAH (0.47) | FAAHZDHHC7TDP1MEN1KMT2A | |
| SCHEMBL28280400 | 0.98 | FAAH (0.46) | FAAHZDHHC7TDP1MEN1KMT2A | |
| SCHEMBL4135628 | 0.98 | FAAH (0.45) | FAAHZDHHC7TDP1MEN1KMT2A | |
| SCHEMBL482827 | 0.94 | TDP1 (0.46) | FAAHZDHHC7TDP1MEN1KMT2A | |
| SCHEMBL650590 | 0.92 | TDP1 (0.45) | FAAHTDP1MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 427 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12398341-B2 | Apparatus and compositions for improving scent delivery | THE PROCTER & GAMBLE COMPANY (US) | 2025-08-26 | — | — | US | claimed |
| CN-119968452-A | Perfume mixture (VI) | 西姆莱斯股份公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119790128-A | Perfume mixture (III) | 西姆莱斯股份公司 | 2025-04-08 | — | — | CN | claimed |
| US-12247180-B2 | Apparatus and compositions for improving scent delivery | THE PROCTER & GAMBLE COMPANY (US) | 2025-03-11 | — | — | US | claimed |
| CN-119317696-A | Perfume mixture (V) | 西姆莱斯股份公司 | 2025-01-14 | — | — | CN | claimed |
| CN-117813077-A | Composition and method for producing the same | 西姆莱斯股份公司 | 2024-04-02 | — | — | CN | claimed |
| EP-4257663-A1 | FOOD CONTACT SURFACE SANITIZING LIQUID | The Procter & Gamble Company (US) | 2023-10-11 | — | — | EP | claimed |
| US-20220002633-A1 | APPARATUS AND COMPOSITIONS FOR IMPROVING SCENT DELIVERY | THE PROCTER AND GAMBLE COMPANY | 2022-01-06 | — | — | US | claimed |
| US-20220002632-A1 | APPARATUS AND COMPOSITIONS FOR IMPROVING SCENT DELIVERY | THE PROCTER AND GAMBLE COMPANY | 2022-01-06 | — | — | US | claimed |
| CN-108430445-A | Spice composition | 西姆莱斯股份公司 | 2018-08-21 | — | — | CN | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| EP-3234094-A1 | IONIC LIQUID SYSTEMS | The Procter and Gamble Company (US) | 2017-10-25 | — | — | EP | claimed |
| WO-2016100123-A1 | IONIC LIQUID SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2016-06-23 | — | — | WO | claimed |
| US-20160177222-A1 | IONIC LIQUID SYSTEMS | THE PROCTER & GAMBLE COMPANY | 2016-06-23 | — | — | US | claimed |
| US-20160152825-A1 | PROCESS FOR PRODUCING COMPOSITES | EVONIK DEGUSSA GMBH (DE) | 2016-06-02 | — | — | US | claimed |
| EP-3026072-A1 | Method for the preparation of composites | Evonik Degussa GmbH (DE) | 2016-06-01 | — | — | EP | claimed |
| CN-1163217-C | Perfume composition | 国际调研有限公司 | 2004-08-25 | — | — | CN | claimed |
| US-6780835-B2 | DEODORANT FOR TREATING TEXTILES INCORPORATING SPANDEX | QUEST INTERNATIONAL B.V. (NL) | 2004-08-24 | — | — | US | claimed |
| CN-1275075-A | Perfume composition | QUEST INT (NL) | 2000-11-29 | — | — | CN | claimed |
| EP-0180745-A1 | Acylacetate and amidine intermediates for pyrimidone compounds, and their preparation | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1986-05-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160177222-A1 | IONIC LIQUID SYSTEMS | CUTA, POLR1C, ELOVL3 | FAAH 1262/4885ZDHHC7 449/4885TDP1 1368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.